M&A Deal Summary |
|
---|---|
Date | 2017-11-06 |
Target | NutraGenesis |
Sector | Consumer Products |
Buyer(s) | Innophos |
Deal Type | Add-on Acquisition |
Deal Value | 28M USD |
Advisor(s) | Alantra Partners, S.A. - Investment Bank (Financial) Downs Rachlin Martin (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Innophos is an international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. Innophos was founded in 2004 and is based in Cranbury, New Jersey.
DEAL STATS | # |
---|---|
Overall | 5 of 5 |
Sector (Consumer Products) | 2 of 2 |
Type (Add-on Acquisition) | 5 of 5 |
State (Vermont) | 1 of 1 |
Country (United States) | 5 of 5 |
Year (2017) | 2 of 2 |
Size (of disclosed) | 3 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-08-01 |
Novel Ingredients
East Hanover, New Jersey, United States Novel Ingredients is a New Jersey-based provider of dietary supplement ingredient solutions. For over 15 years, Novel Ingredients has established a standard of excellence in the distribution of premium botanical ingredients. |
Buy | $125M |